Dr. Albin is the Anne B. Young Collegiate Professor of Neurology and chief of Neuroscience Research at the VA Ann Arbor Health System, and co-director of the University of Michigan Udall Center. His primary research interest is on the clinical manifestations of basal ganglia disorders, notably Parkinson’s disease. With Drs. Anne Young and Jack Penney, he has proposed the most influential model of basal ganglia dysfunction. Dr. Albin's past work includes both laboratory and clinical research on Parkinson’s disease, Huntington’s disease and Tourette syndrome, and his recent work focuses on the effect of non-motor and dopamine replacement on the non-responsive features of Parkinson’s disease. This research uses state-of-the-art imaging methods to understand the changes in neurochemical systems driving these important features of Parkinson’s disease. Major areas of study also include the impacts of changes in brain cholinergic and serotoninergic systems on Parkinson’s disease.
Associated Grants
-
Alpha4Beta2 Nicotinic Agonist for Treatment of L-Dopa Refractory Gait and Balance Disorders in Parkinson Disease
2015
-
Treating Early Cognitive Impairments and Associated Movement Control Deficits by Stimulating alpha4beta2* nAChRs
2010
-